| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:621757 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of CASP4 mRNA] | CTD | PMID:19414516 |
| 1,2,4-trimethylbenzene | decreases expression | ISO | RGD:621757 | 6480464 | pseudocumene results in decreased expression of CASP4 protein | CTD | PMID:17337753 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CASP4 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CASP4 mRNA | CTD | PMID:23373633 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CASP4 mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553228 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CASP4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:621757 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CASP4 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1553228 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASP4 mRNA | CTD | PMID:12167310 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASP4 mRNA | CTD | PMID:11007951 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:621757 | 6480464 | 2,4-dinitrotoluene affects the expression of CASP4 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:1553228 | 6480464 | Glucosamine results in decreased expression of CASP4 mRNA | CTD | PMID:17178593 |
| 3-methyladenine | increases activity | EXP | | 6480464 | 3-methyladenine results in increased activity of CASP4 protein | CTD | PMID:20371669 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1553228 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CASP4 mRNA | CTD | PMID:19191707 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CASP4 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 PMID:15352031 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CASP4 protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 PMID:16217747 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CASP4 protein | CTD | PMID:15352031 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:1553228 | 6480464 | Glucosamine results in decreased expression of CASP4 mRNA | CTD | PMID:17178593 |
| ammonium chloride | increases expression | ISO | RGD:621757 | 6480464 | Ammonium Chloride results in increased expression of CASP4 protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | ISO | RGD:621757 | 6480464 | Ammonium Chloride affects the expression of CASP4 mRNA | CTD | PMID:16483693 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of CASP4 mRNA | CTD | PMID:11134558 |
| arsenite(3-) | decreases expression | ISO | RGD:1553228 | 6480464 | arsenite results in decreased expression of CASP4 mRNA | CTD | PMID:18191166 |
| bafilomycin A1 | increases activity | EXP | | 6480464 | bafilomycin A1 results in increased activity of CASP4 protein | CTD | PMID:20371669 |
| benzene | increases expression | ISO | RGD:1553228 | 6480464 | Benzene results in increased expression of CASP4 mRNA | CTD | PMID:12928149 |
| benzene | multiple interactions | ISO | RGD:1553228 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of CASP4 mRNA] | CTD | PMID:12928149 |
| benzo[a]pyrene | increases expression | ISO | RGD:1553228 | 6480464 | Benzo(a)pyrene results in increased expression of CASP4 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CASP4 mRNA | CTD | PMID:21632981 |
| beta-D-glucosamine | decreases expression | ISO | RGD:1553228 | 6480464 | Glucosamine results in decreased expression of CASP4 mRNA | CTD | PMID:17178593 |
| cadmium dichloride | increases expression | ISO | RGD:621757 | 6480464 | Cadmium Chloride results in increased expression of CASP4 mRNA | CTD | PMID:22110744 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CASP4 mRNA | CTD | PMID:16002434 |
| capsaicin | increases expression | ISO | RGD:621757 | 6480464 | Capsaicin results in increased expression of CASP4 mRNA | CTD | PMID:20349343 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin results in increased cleavage of and results in increased activity of CASP4 protein | CTD | PMID:19699254 PMID:19139269 |
| capsaicin | increases activity | EXP | | 6480464 | Capsaicin results in increased activity of CASP4 protein | CTD | PMID:20371669 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin results in increased cleavage of and results in increased activity of CASP4 protein | CTD | PMID:19139269 PMID:19699254 |
| cholesterol | multiple interactions | ISO | RGD:621757 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of CASP4 mRNA]; more ... | CTD | PMID:19477266 |
| cholesterol | increases expression | ISO | RGD:621757 | 6480464 | Cholesterol analog results in increased expression of CASP4 mRNA | CTD | PMID:19477266 |
| choline | multiple interactions | ISO | RGD:1553228 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CASP4 mRNA | CTD | PMID:20938992 |
| cisplatin | multiple interactions | EXP | | 6480464 | [vorinostat co-treated with Cisplatin] results in increased activity of CASP4 protein | CTD | PMID:19280190 |
| cisplatin | decreases expression | ISO | RGD:621757 | 6480464 | Cisplatin results in decreased expression of CASP4 mRNA | CTD | PMID:22023808 |
| cisplatin | increases activity | EXP | | 6480464 | Cisplatin results in increased activity of CASP4 protein | CTD | PMID:16357177 |
| cisplatin | increases response to substance | EXP | | 6480464 | CASP4 protein results in increased susceptibility to Cisplatin | CTD | PMID:16357177 |
| cisplatin | multiple interactions | EXP | | 6480464 | CASP4 protein results in increased susceptibility to [Cisplatin co-treated with bortezomib] | CTD | PMID:16357177 |
| clofibric acid | multiple interactions | ISO | RGD:621757 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CASP4 mRNA | CTD | PMID:17602206 |
| cocaine | affects expression | ISO | RGD:1553228 | 6480464 | Cocaine affects the expression of CASP4 mRNA | CTD | PMID:15681117 |
| cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of CASP4 mRNA | CTD | PMID:12629581 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CASP4 mRNA | CTD | PMID:20971185 |
| copper atom | increases expression | ISO | RGD:621757 | 6480464 | Copper results in increased expression of CASP4 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CASP4 mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | ISO | RGD:621757 | 6480464 | Copper results in increased expression of CASP4 mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of CASP4 mRNA | CTD | PMID:19549813 |
| corticosterone | decreases expression | ISO | RGD:621757 | 6480464 | Corticosterone results in decreased expression of CASP4 mRNA | CTD | PMID:15755911 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CASP4 mRNA | CTD | PMID:16101141 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CASP4 mRNA] | CTD | PMID:11007951 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CASP4 mRNA | CTD | PMID:20106945 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:621757 | 6480464 | Tetrahydrocannabinol results in increased expression of CASP4 mRNA | CTD | PMID:16616335 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1553228 | 6480464 | Tetrahydrocannabinol results in increased expression of CASP4 mRNA | CTD | PMID:21542829 |
| dexamethasone | increases expression | ISO | RGD:1553228 | 6480464 | Dexamethasone results in increased expression of CASP4 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | increases activity | EXP | | 6480464 | arsenic trioxide results in increased activity of CASP4 protein | CTD | PMID:20138156 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CASP4 mRNA | CTD | PMID:11940349 |
| diarsenic trioxide | increases expression | ISO | RGD:621757 | 6480464 | arsenic trioxide results in increased expression of CASP4 mRNA | CTD | PMID:19730151 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [arsenic trioxide results in increased activity of CASP4 protein] | CTD | PMID:20138156 |
| diazinon | decreases expression | ISO | RGD:621757 | 6480464 | Diazinon results in decreased expression of CASP4 mRNA | CTD | PMID:17452286 |
| dihydrocapsaicin | multiple interactions | EXP | | 6480464 | dihydrocapsaicin results in increased cleavage of and results in increased activity of CASP4 protein | CTD | PMID:19139269 |
| fenofibrate | increases expression | ISO | RGD:621757 | 6480464 | Fenofibrate results in increased expression of CASP4 mRNA | CTD | PMID:17264098 |
| folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of CASP4 mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:1553228 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CASP4 mRNA | CTD | PMID:20938992 |
| fulvestrant | increases expression | EXP | | 6480464 | fulvestrant results in increased expression of CASP4 mRNA | CTD | PMID:12154049 |
| furosemide | affects expression | ISO | RGD:621757 | 6480464 | Furosemide affects the expression of CASP4 mRNA | CTD | PMID:17497460 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CASP4 mRNA | CTD | PMID:20044591 |
| indole-3-methanol | affects expression | ISO | RGD:621757 | 6480464 | indole-3-carbinol affects the expression of CASP4 mRNA | CTD | PMID:21396975 |
| isoflurane | decreases expression | ISO | RGD:621757 | 6480464 | Isoflurane results in decreased expression of CASP4 mRNA | CTD | PMID:16978161 |
| kojic acid | multiple interactions | ISO | RGD:621757 | 6480464 | Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA] | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | ISO | RGD:621757 | 6480464 | Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA] | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:1553228 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CASP4 mRNA | CTD | PMID:20938992 |
| lithium atom | multiple interactions | ISO | RGD:621757 | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of CASP4 mRNA] | CTD | PMID:19149911 |
| menadione | multiple interactions | EXP | | 6480464 | [Metyrapone co-treated with Vitamin K 3] affects the localization of CASP4 protein; more ... | CTD | PMID:19819344 |
| methamphetamine | multiple interactions | ISO | RGD:621757 | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of CASP4 mRNA]; more ... | CTD | PMID:19149911 |
| methamphetamine | increases expression | ISO | RGD:621757 | 6480464 | Methamphetamine results in increased expression of CASP4 mRNA | CTD | PMID:19149911 |
| methapyrilene | increases expression | ISO | RGD:621757 | 6480464 | Methapyrilene results in increased expression of CASP4 mRNA | CTD | PMID:17450226 |
| metyrapone | multiple interactions | EXP | | 6480464 | [Metyrapone co-treated with Vitamin K 3] affects the localization of CASP4 protein | CTD | PMID:19819344 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1553228 | 6480464 | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CASP4 mRNA] | CTD | PMID:16137721 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:621757 | 6480464 | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP4 mRNA] | CTD | PMID:19477266 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in increased expression of CASP4 mRNA | CTD | PMID:12634122 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621757 | 6480464 | Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA] | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621757 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CASP4 mRNA | CTD | PMID:17602206 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of CASP4 mRNA | CTD | PMID:18058816 |
| paracetamol | affects expression | ISO | RGD:1553228 | 6480464 | Acetaminophen affects the expression of CASP4 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CASP4 mRNA | CTD | PMID:21420995 PMID:22230336 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CASP4 mRNA | CTD | PMID:21420995 |
| perfluorooctanoic acid | increases expression | ISO | RGD:621757 | 6480464 | perfluorooctanoic acid results in increased expression of CASP4 mRNA | CTD | PMID:16221955 |
| pirinixic acid | decreases expression | ISO | RGD:1553228 | 6480464 | pirinixic acid results in decreased expression of CASP4 mRNA | CTD | PMID:17426115 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of CASP4 mRNA | CTD | PMID:12154049 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of CASP4 protein | CTD | PMID:20717957 |
| resveratrol | affects response to substance | EXP | | 6480464 | CASP4 protein affects the susceptibility to resveratrol | CTD | PMID:20198347 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of CASP4 mRNA | CTD | PMID:17639046 |
| rotenone | increases expression | ISO | RGD:621757 | 6480464 | Rotenone results in increased expression of CASP4 mRNA | CTD | PMID:19013527 |
| silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of CASP4 mRNA | CTD | PMID:22342292 |
| silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of CASP4 mRNA | CTD | PMID:22342292 |
| thapsigargin | multiple interactions | EXP | | 6480464 | Thapsigargin results in increased cleavage of and results in increased activity of CASP4 protein | CTD | PMID:17559149 |
| trans-resveratrol | affects response to substance | EXP | | 6480464 | CASP4 protein affects the susceptibility to resveratrol | CTD | PMID:20198347 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of CASP4 protein | CTD | PMID:20717957 |
| tunicamycin | decreases expression | ISO | RGD:1553228 | 6480464 | Tunicamycin results in decreased expression of CASP4 mRNA | CTD | PMID:17127020 |
| valproic acid | multiple interactions | ISO | RGD:621757 | 6480464 | Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of CASP4 mRNA] | CTD | PMID:19149911 |